The overlooked challenge of perioperative hypertension: unveiling pathophysiology and redefining management strategies.

IF 2.2 4区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Pandit Bagus Tri Saputra, Wynne Widarti, Sherly Yolanda, Ryan Arya Hidayat, Rendra Mahardhika Putra, Prihatma Kriswidyatomo, Novia Nurul Faizah, Firas Farisi Alkaff
{"title":"The overlooked challenge of perioperative hypertension: unveiling pathophysiology and redefining management strategies.","authors":"Pandit Bagus Tri Saputra, Wynne Widarti, Sherly Yolanda, Ryan Arya Hidayat, Rendra Mahardhika Putra, Prihatma Kriswidyatomo, Novia Nurul Faizah, Firas Farisi Alkaff","doi":"10.1080/03007995.2025.2576594","DOIUrl":null,"url":null,"abstract":"<p><p>Hypertension, defined as a systolic blood pressure (BP) ≥ 140 mmHg or diastolic BP ≥ 90 mmHg, presents a significant challenge in perioperative settings. Perioperative hypertension-elevated BP occurring in preoperative, intraoperative, or postoperative phases-is highly prevalent, affecting 20-25% of patients undergoing non-cardiac procedures and up to 80% of those undergoing cardiac surgeries. This review aims to provide an in-depth examination of perioperative hypertension, emphasizing its impact on patient outcomes, current management strategies, and the need for standardized guidelines. This review synthesizes existing literature on perioperative hypertension, including its definitions, classifications, pathophysiology, and management approaches. Evidence from observational studies, clinical trials, and expert guidelines is analyzed to highlight gaps and best practices in perioperative BP control. A comprehensive literature review was conducted using scientific databases. Studies examining the incidence, complications, and management strategies of perioperative hypertension were included. Quantitative findings on the association between perioperative BP variations and clinical outcomes were also reviewed. Perioperative hypertension significantly increases the risk of adverse cardiovascular events, including myocardial infarction, stroke, and renal failure, contributing to longer hospital stays and higher healthcare costs. Patients with significant intraoperative systolic BP elevations had markedly higher risks of adverse outcomes, including approximately 1.5-fold higher mortality and a doubling of renal failure risk. Additionally, hypertension is a leading cause of elective surgery postponement. Despite its high prevalence, comprehensive management guidelines remain inadequate, resulting in inconsistent BP control strategies and suboptimal patient outcomes. The management of perioperative hypertension requires a more standardized and evidence-based approach. Current strategies emphasize individualized BP targets, optimization of antihypertensive therapy, and intraoperative hemodynamic stability. However, the lack of universally accepted guidelines hinders effective BP management. Future research should focus on developing standardized protocols to improve perioperative outcomes and reduce complications related to hypertension.</p>","PeriodicalId":10814,"journal":{"name":"Current Medical Research and Opinion","volume":" ","pages":"1-15"},"PeriodicalIF":2.2000,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Medical Research and Opinion","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/03007995.2025.2576594","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Hypertension, defined as a systolic blood pressure (BP) ≥ 140 mmHg or diastolic BP ≥ 90 mmHg, presents a significant challenge in perioperative settings. Perioperative hypertension-elevated BP occurring in preoperative, intraoperative, or postoperative phases-is highly prevalent, affecting 20-25% of patients undergoing non-cardiac procedures and up to 80% of those undergoing cardiac surgeries. This review aims to provide an in-depth examination of perioperative hypertension, emphasizing its impact on patient outcomes, current management strategies, and the need for standardized guidelines. This review synthesizes existing literature on perioperative hypertension, including its definitions, classifications, pathophysiology, and management approaches. Evidence from observational studies, clinical trials, and expert guidelines is analyzed to highlight gaps and best practices in perioperative BP control. A comprehensive literature review was conducted using scientific databases. Studies examining the incidence, complications, and management strategies of perioperative hypertension were included. Quantitative findings on the association between perioperative BP variations and clinical outcomes were also reviewed. Perioperative hypertension significantly increases the risk of adverse cardiovascular events, including myocardial infarction, stroke, and renal failure, contributing to longer hospital stays and higher healthcare costs. Patients with significant intraoperative systolic BP elevations had markedly higher risks of adverse outcomes, including approximately 1.5-fold higher mortality and a doubling of renal failure risk. Additionally, hypertension is a leading cause of elective surgery postponement. Despite its high prevalence, comprehensive management guidelines remain inadequate, resulting in inconsistent BP control strategies and suboptimal patient outcomes. The management of perioperative hypertension requires a more standardized and evidence-based approach. Current strategies emphasize individualized BP targets, optimization of antihypertensive therapy, and intraoperative hemodynamic stability. However, the lack of universally accepted guidelines hinders effective BP management. Future research should focus on developing standardized protocols to improve perioperative outcomes and reduce complications related to hypertension.

围手术期高血压被忽视的挑战:揭示病理生理学和重新定义管理策略。
高血压,定义为收缩压(BP)≥140 mmHg或舒张压≥90 mmHg,在围手术期提出了重大挑战。围手术期高血压(术前、术中或术后血压升高)非常普遍,影响20-25%的非心脏手术患者和高达80%的心脏手术患者。本综述旨在对围手术期高血压进行深入研究,强调其对患者预后的影响、当前的管理策略以及标准化指南的必要性。本文综述了围手术期高血压的相关文献,包括高血压的定义、分类、病理生理学和治疗方法。本文分析了观察性研究、临床试验和专家指南的证据,以突出围手术期血压控制的差距和最佳实践。利用科学数据库进行了全面的文献综述。研究包括围手术期高血压的发生率、并发症和处理策略。我们也回顾了围手术期血压变化与临床结果之间的定量研究结果。围手术期高血压显著增加不良心血管事件的风险,包括心肌梗死、中风和肾衰竭,导致住院时间更长,医疗费用更高。术中收缩压明显升高的患者出现不良结局的风险明显增加,包括死亡率增加约1.5倍,肾功能衰竭风险增加一倍。此外,高血压是择期手术推迟的主要原因。尽管其发病率很高,但综合管理指南仍然不足,导致血压控制策略不一致和患者预后不佳。围手术期高血压的管理需要更加标准化和循证的方法。目前的策略强调个体化血压目标、优化降压治疗和术中血流动力学稳定性。然而,缺乏普遍接受的指导方针阻碍了有效的BP管理。未来的研究应侧重于制定标准化的方案,以改善围手术期的预后,减少高血压相关的并发症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Medical Research and Opinion
Current Medical Research and Opinion 医学-医学:内科
CiteScore
4.40
自引率
4.30%
发文量
247
审稿时长
3-8 weeks
期刊介绍: Current Medical Research and Opinion is a MEDLINE-indexed, peer-reviewed, international journal for the rapid publication of original research on new and existing drugs and therapies, Phase II-IV studies, and post-marketing investigations. Equivalence, safety and efficacy/effectiveness studies are especially encouraged. Preclinical, Phase I, pharmacoeconomic, outcomes and quality of life studies may also be considered if there is clear clinical relevance
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信